Prevail Therapeutics
ID: 5329328Prevail Therapeutics is a New York City-based biotechnology company and a wholly owned subsidiary of Eli Lilly and Company.
3
Funding Rounds
$129.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| As* Ab******** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| As* Ab******** | - | - |
Funding
Funding series
Funding Series Analysis
The company Prevail Therapeutics has raised a total of $129m in funding over 3 rounds.
Key Insights:
- Prevail Therapeutics Series B round, March 2019: $50m
- Prevail Therapeutics Series A round, March 8, 2018: $75m
- Prevail Therapeutics Seed round, August 1, 2017: $4m
Industries
Prevail Therapeutics is active in the following industries: